4DMedical (ASX:4DX) said its operating revenue for the fiscal first half came in at AU$2.9 million, with its underlying software-as-a-service revenue up 31% year-over-year, according to a Friday Australian bourse filing.
It expanded its existing distribution agreement with Koninklijke Philips, under which Philips will distribute CT:VQ, the firm's computed tomography-based ventilation-perfusion imaging technology, to healthcare systems across the US and Canada on full commercial terms.
The agreement includes a mechanism wherein Philips underwrites the minimum order commitment of around AU$15 million in customer orders over 2026 and 2027.
Its shares jumped 6% in recent trading on Friday.